Analyst Price Targets — IRON
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 15, 2026 8:02 pm | — | Morgan Stanley | $85.00 | $70.09 | TheFly | Disc Medicine price target raised to $85 from $80 at Morgan Stanley |
| May 14, 2026 12:09 pm | — | Morgan Stanley | $80.00 | $69.30 | TheFly | Disc Medicine price target raised to $80 from $75 at Morgan Stanley |
| February 17, 2026 1:34 pm | — | Wedbush | $88.00 | $60.28 | TheFly | Disc Medicine price target lowered to $88 from $110 at Wedbush |
| February 17, 2026 1:21 pm | Kristen Kluska | Cantor Fitzgerald | $125.00 | $60.24 | TheFly | Disc Medicine price target lowered to $125 from $153 at Cantor Fitzgerald |
| February 17, 2026 1:14 pm | — | Morgan Stanley | $75.00 | $60.39 | TheFly | Disc Medicine price target lowered to $75 from $120 at Morgan Stanley |
| February 17, 2026 1:05 pm | — | Stifel Nicolaus | $110.00 | $61.43 | TheFly | Disc Medicine price target lowered to $110 from $125 at Stifel |
| February 17, 2026 12:56 pm | Evan Seigerman | BMO Capital | $100.00 | $61.48 | TheFly | Disc Medicine price target lowered to $100 from $120 at BMO Capital |
| January 8, 2026 12:40 pm | — | Morgan Stanley | $120.00 | $80.94 | TheFly | Disc Medicine price target raised to $120 from $115 at Morgan Stanley |
| December 8, 2025 1:20 pm | Martin Auster | Raymond James | $117.00 | $96.32 | StreetInsider | Disc Medicine (IRON) PT Raised to $117 at Raymond James |
| November 10, 2025 2:52 pm | — | Truist Financial | $114.00 | $82.77 | TheFly | Disc Medicine price target raised to $114 from $86 at Truist |
Latest News for IRON
NEW YORK, July 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. So What: If you purchased Disc Medicine securities you may be entitled to…
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
NEW YORK, July 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. So What: If you purchased Disc Medicine securities you may be entitled to…
Shares in Ironveld PLC (AIM:IRON) jumped 32% to 0.025p after the mining developer said its processing plant had reached sustained production and secured strong commercial demand. Ironveld, an AIM-listed company producing strategic metals for mineral processing, said its dense media separation plant was now running continuously for 16 hours a day on a double shift.
New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Disc Medicine securities you may be…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for IRON.
U.S. House Trading
No House trades found for IRON.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.